Synapse - Joachim Yahalom

Search Within

Joachim Yahalom

Results (625)

Clinical features and outcome of primary pancreatic lymphoma

Journal Article

Sadot, E.; Yahalom, J.; Do, R. K. G.; Teruya-Feldstein, J.; Allen, P. J.; Gönen, M.; D'Angelica, M. I.; Kingham, T. P.; Jarnagin, W. R.; DeMatteo, R. P.
Annals of Surgical Oncology (2015)

Fulltext@MSK | Save

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

Journal Article

Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L. E.; more...
Journal of the National Comprehensive Cancer Network (2015)

Fulltext@MSK | Save

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study

Journal Article

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Lancet Oncology (2015)

Fulltext@MSK | Save

Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
Blood (2014)

Fulltext@MSK | Save

Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience

Meeting Abstract

Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Comment on: “clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large b-cell lymphoma of the bone (the ielsg-14 study)”

Journal Article

Hoope, R.; Illidge, T.; Specht, L.; Vogelius, I.; Yahalom, J.
The Oncologist (2014)

Fulltext@MSK | Save

Chemotherapy only in early-stage Hodgkin lymphoma: More relapses but “same” (or possibly worse) survival – Reconsidering the misguided trend to omit radiotherapy

Journal Article

Yahalom, J.
Current Hematologic Malignancy Reports (2014)

Fulltext@MSK | Save

Radiation oncology

Book Section

Gupta, G. P.; Rosenstein, B. S.; Teckie, S.; Lanning, R. M.; Powell, S. N.; Spratt, D. E.; Reyngold, M.; Yamada, Y.; Folkert, M. R.; Zelefsky, M. J.; more...
In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

Fulltext@MSK | Save

Early-stage Hodgkin disease: The utilization of radiation therapy and its impact on overall survival

Meeting Abstract

Parikh, R. R.; Yahalom, J.; Talcott, J. A.; Grossbard, M. L.; Harrison, L. B.
International Journal of Radiation Oncology, Biology, Physics (2014)

Fulltext@MSK | Save

Characteristics and outcomes of patients with lymphocyte-predominant Hodgkin lymphoma versus classical Hodgkin lymphoma: A population-based analysis

Meeting Abstract

Gerber, N.; Atoria, C. L.; Elkin, E. B.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2014)

Fulltext@MSK | Save